Biomimetic functionalization with leukocyte membranes imparts cell like functions to synthetic particles

The therapeutic efficacy of systemic drug delivery vehicles depends on their ability to evade the immune system, cross the biological barriers of the body and localize at target tissues. Leukocytes possess all of these functions and exert their targeting ability through cellular membrane interaction...

Full description

Saved in:
Bibliographic Details
Published inNature nanotechnology Vol. 8; no. 1; pp. 61 - 68
Main Authors Parodi, Alessandro, Quattrocchi, Nicoletta, van de Ven, Anne L., Chiappini, Ciro, Evangelopoulos, Michael, Martinez, Jonathan O., Brown, Brandon S., Khaled, Sm Z., Yazdi, Iman K., Enzo, Maria Vittoria, Isenhart, Lucas, Ferrari, Mauro, Tasciotti, Ennio
Format Journal Article
LanguageEnglish
Published 16.12.2012
Online AccessGet full text

Cover

Loading…
More Information
Summary:The therapeutic efficacy of systemic drug delivery vehicles depends on their ability to evade the immune system, cross the biological barriers of the body and localize at target tissues. Leukocytes possess all of these functions and exert their targeting ability through cellular membrane interactions. Here we show that NanoPorous Silicon particles (NPS) can successfully perform all these actions when coated with cellular membranes purified from white blood cells. These hybrid particles called LeukoLike Vectors (LLV) were able to: prevent rapid clearance of phagocytic cells of the immune system; communicate with endothelial cells through receptor-ligand interaction; transport and release a payload across an inflamed reconstructed endothelium. Furthermore, LLV retained their functions when injected in vivo , showing enhanced circulation time and improved accumulation in the tumour.
Bibliography:These authors contributed equally to this work.
Current address: Department of Materials, Imperial College London.
ISSN:1748-3387
1748-3395
DOI:10.1038/nnano.2012.212